Targets of the PI3K pathway were also found to be significantly dephosphorylated in cells where BAG3 was silenced such as AKT, mTOR and the p70S6K that also were found to be interesting targets to overcome acquired resistance to to BRAFV600E inhibition in melanoma [29]. Here, RPS6KB1 is linked to melanoma.